Targeting cathepsins: A new glimmer of hope for pancreatic cancer therapy?

Gut

Volumn 61, Issue 6, 2012, Pages 790-791

  Michl, Patrick ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN INHIBITOR; CATHEPSIN L; CYSTEINE PROTEINASE INHIBITOR; GEMCITABINE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALLELE; ALTERNATIVE RNA SPLICING; ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL COMPONENT; COMPLEX FORMATION; CROSS BREEDING; DISEASE ASSOCIATION; DISEASE MODEL; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG RESEARCH; ENDOLYSOSOME; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; GENE AMPLIFICATION; HUMAN; INSULINOMA; KNOCKOUT MOUSE; METASTASIS; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; NONHUMAN; NOTE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; STROMA; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CATHEPSIN B; PANCREATIC NEOPLASMS;

EID: 84860557891     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301816     Document Type: Note

References (14)

1. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007;7:800-8. (Pubitemid 47463671)
2. Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006;6:764-75. (Pubitemid 44450465)
3. Niedergethmann M, Wostbrock B, Sturm JW, et al. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma. Pancreas 2004;29:204-11. (Pubitemid 39304977)
4. Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol 2011;21:228-37.
5. Sameni M, Dosescu J, Moin K, et al. Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Mol Imaging 2003;2:159-75.
6. Schraufstatter IU, Trieu K, Zhao M, et al. IL-8- mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor. J Immunol 2003;171:6714-22. (Pubitemid 37532104)
7. Gocheva V, Zeng W, Ke D, et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006;20:543-56. (Pubitemid 43345321)
8. Vasiljeva O, Papazoglou A, Kruger A, et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 2006;66:5242-50. (Pubitemid 43844948)
9. Gopinathan A, Denicola GM, Frese KK, et al Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Gut 2012;61:877-84.
10. Goulet B, Sansregret L, Leduy L, et al. Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 2007;5:899-907. (Pubitemid 47416667)
11. Malla RR, Gopinath S, Gondi CS, et al. Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma. Cancer Gene Ther 2011;18:419-34.
12. Moore MJ, Hamm J, Dancey J, et al. Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2003;21:3296-302. (Pubitemid 46606263)
13. Joyce JA, Baruch A, Chehade K, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;5:443-53. (Pubitemid 38610246)
14. Panchal RG, Cusack E, Cheley S, et al. Tumor protease-activated, pore-forming toxins from a combinatorial library. Nat Biotechnol 1996;14:852-6. (Pubitemid 26239183)